Health
Human recombinant soluble ACE2 successfully used in a patient with severe COVID-19 – News-Medical.Net
A multinational research group recently published a paper in the journal Lancet Respiratory Medicine which describes the first patient with a severe form of coronavirus disease (COVID-19) that was successfully treated with human recombinant soluble ACE2.

A multinational research group recently published a paper in the journal Lancet Respiratory Medicine which describes the first patient with a severe form of coronavirus disease (COVID-19) that was successfully treated with human recombinant soluble ACE2.
A pandemic spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for almost one million deaths due to COVID-19. Therefore, important insights into the viral pathophysiology may facilitate the quest for an eff…
-
General20 hours ago
Of saints and sinners | The Spectator Australia
-
General20 hours ago
Small plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News11 hours ago
Tully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General20 hours ago
Why the nation needs the Nationals to ditch Net Zero